来自 SSO 内分泌和头颈部疾病网站工作组的关于嗜铬细胞瘤和副神经节瘤的更新，第 2 部分，共 2 部分：嗜铬细胞瘤和副神经节瘤的围手术期管理和结果。
Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma.
机构信息
Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.
Department of Surgery, The Ohio State University, Columbus, OH, USA.
出版信息
Ann Surg Oncol. 2020 May;27(5):1338-1347. doi: 10.1245/s10434-020-08221-2. Epub 2020 Feb 28.
Abstract
This is the second part of a two-part review on pheochromocytoma and paragangliomas (PPGLs). In this part, perioperative management, including preoperative preparation, intraoperative, and postoperative interventions are reviewed. Current data on outcomes following resection are presented, including outcomes after cortical-sparing adrenalectomy for bilateral adrenal disease. In addition, pathological features of malignancy, surveillance considerations, and the management of advanced disease are also discussed.
摘要
这是关于嗜铬细胞瘤和副神经节瘤（PPGLs）的两部分综述的第二部分。在这一部分中，回顾了围手术期管理，包括术前准备、术中及术后干预。介绍了目前关于切除术后结果的数据，包括双侧肾上腺疾病行保留皮质肾上腺切除术的结果。此外，还讨论了恶性肿瘤的病理特征、监测注意事项以及晚期疾病的治疗。
相似文献
1
Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma.
Ann Surg Oncol. 2020 May;27(5):1338-1347. doi: 10.1245/s10434-020-08221-2. Epub 2020 Feb 28.
2
Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
Surgery. 2017 Dec;162(6):1259-1269. doi: 10.1016/j.surg.2017.08.002. Epub 2017 Sep 14.
3
Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma.
Ann Surg Oncol. 2020 May;27(5):1329-1337. doi: 10.1245/s10434-020-08220-3. Epub 2020 Feb 28.
4
Preoperative Management of Pheochromocytoma and Paraganglioma.
Front Endocrinol (Lausanne). 2020 Sep 29;11:586795. doi: 10.3389/fendo.2020.586795. eCollection 2020.
5
Surgical management of hereditary pheochromocytoma.
J Am Coll Surg. 2004 Apr;198(4):525-34; discussion 534-5. doi: 10.1016/j.jamcollsurg.2003.12.001.
6
Laparoscopic resection of periadrenal paraganglioma in a patient with multiple endocrine neoplasia type 2A.
Surg Laparosc Endosc Percutan Tech. 2011 Feb;21(1):e31-3. doi: 10.1097/SLE.0b013e3182074c72.
7
Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas.
J Urol. 1998 Aug;160(2):330-4. doi: 10.1016/s0022-5347(01)62886-6.
8
Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features.
Endocrine. 2014 Apr;45(3):469-78. doi: 10.1007/s12020-013-0007-y. Epub 2013 Jul 2.
9
MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma.
Eur J Endocrinol. 2016 Jan;174(1):R9-18. doi: 10.1530/EJE-15-0549. Epub 2015 Aug 21.
10
Pheochromocytoma/Paraganglioma: Review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma.
J Clin Hypertens (Greenwich). 2013 Jun;15(6):428-34. doi: 10.1111/jch.12084. Epub 2013 Mar 15.
引用本文的文献
1
Pheochromocytomas and Paragangliomas-Current Management.
Cancers (Basel). 2025 Mar 19;17(6):1029. doi: 10.3390/cancers17061029.
2
Carotid stenosis complicating a vagus paraganglioma: A dually rare case.
Int J Surg Case Rep. 2025 Jan;126:110751. doi: 10.1016/j.ijscr.2024.110751. Epub 2024 Dec 17.
3
Circulatory characteristics of early mobilization after surgery for bilateral pheochromocytoma: a case report.
J Med Case Rep. 2024 Oct 31;18(1):529. doi: 10.1186/s13256-024-04833-4.
4
Progress in surgical approaches and outcomes of patients with pheochromocytoma and paraganglioma.
Best Pract Res Clin Endocrinol Metab. 2025 Jan;39(1):101954. doi: 10.1016/j.beem.2024.101954. Epub 2024 Sep 21.
5
Paraganglioma of the Neck: A Rare Case With Spinal Metastasis.
Case Rep Oncol Med. 2024 Apr 26;2024:2025115. doi: 10.1155/2024/2025115. eCollection 2024.
6
Effects of Peptide Receptor Radiotherapy in Patients with Advanced Paraganglioma and Pheochromocytoma: A Nation-Wide Cohort Study.
Cancers (Basel). 2024 Mar 29;16(7):1349. doi: 10.3390/cancers16071349.
7
Expression of EMP 1, 2, and 3 in Adrenal Cortical Neoplasm and Pheochromocytoma.
Int J Mol Sci. 2023 Aug 21;24(16):13016. doi: 10.3390/ijms241613016.
8
Pheochromocytoma: Clinical Experience From a Single Tertiary Care Center in India.
Cureus. 2023 Jul 10;15(7):e41671. doi: 10.7759/cureus.41671. eCollection 2023 Jul.
9
Histone deacetylase inhibitors as a novel therapeutic approach for pheochromocytomas and paragangliomas.
Oncol Res. 2023 Feb 3;30(5):211-219. doi: 10.32604/or.2022.026913. eCollection 2022.
10
Abandonment of intravenous volume expansion after preoperative receipt of α-blockers in patients with adrenal pheochromocytoma was not an independent risk factor for intraoperative hemodynamic instability.
Front Endocrinol (Lausanne). 2023 Apr 21;14:1131564. doi: 10.3389/fendo.2023.1131564. eCollection 2023.
本文引用的文献
1
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
J Clin Endocrinol Metab. 2020 Jul 1;105(7):2381-91. doi: 10.1210/clinem/dgz188.
2
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.
J Natl Compr Canc Netw. 2018 Jun;16(6):693-702. doi: 10.6004/jnccn.2018.0056.
3
Minimally Invasive Surgery (MIS) in Children and Adolescents with Pheochromocytomas and Retroperitoneal Paragangliomas: Experiences in 42 Patients.
World J Surg. 2018 Apr;42(4):1024-1030. doi: 10.1007/s00268-018-4488-y.
4
A cost-conscious approach to robotic adrenalectomy.
J Robot Surg. 2018 Dec;12(4):607-611. doi: 10.1007/s11701-018-0782-9. Epub 2018 Jan 31.
5
Fifteen years of adrenalectomies: impact of specialty training and operative volume.
Surgery. 2018 Jan;163(1):150-156. doi: 10.1016/j.surg.2017.05.024. Epub 2017 Nov 8.
6
Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery.
Surgery. 2018 Jan;163(1):191-196. doi: 10.1016/j.surg.2017.05.025. Epub 2017 Nov 7.
7
Each procedure matters: threshold for surgeon volume to minimize complications and decrease cost associated with adrenalectomy.
Surgery. 2018 Jan;163(1):157-164. doi: 10.1016/j.surg.2017.04.028. Epub 2017 Nov 6.
8
Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
Ann Surg Oncol. 2017 Nov;24(12):3624-3630. doi: 10.1245/s10434-017-6074-1. Epub 2017 Sep 7.
9
Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years.
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3296-3305. doi: 10.1210/jc.2017-00992.
10
ENDOCRINOLOGY IN PREGNANCY: Pheochromocytoma in pregnancy: case series and review of literature.
Eur J Endocrinol. 2017 Aug;177(2):R49-R58. doi: 10.1530/EJE-16-0920. Epub 2017 Apr 5.
Zotero 插件